Literature DB >> 17040836

Is Schistosomicidal Chemotherapy Sub-curative? Implications for Drug Resistance.

M J Doenhoff1.   

Abstract

Year:  1998        PMID： 17040836     DOI： 10.1016/s0169-4758(98)01315-5

Source DB:  PubMed          Journal:  Parasitol Today        ISSN： 0169-4758


× No keyword cloud information.
  14 in total

Review 1.  Drug resistance in human helminths: current situation and lessons from livestock.

Authors:  S Geerts; B Gryseels
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Development and validation of a 'tablet pole' for the administration of praziquantel in sub-Saharan Africa.

Authors:  A Montresor; D Engels; L Chitsulo; D A Bundy; S Brooker; L Savioli
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Sep-Oct       Impact factor: 2.184

Review 3.  Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.

Authors:  Jürg Utzinger; Jennifer Keiser; Xiao Shuhua; Marcel Tanner; Burton H Singer
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

4.  Comparison of Schistosoma mansoni soluble cercarial antigens and soluble egg antigens for serodiagnosing schistosome infections.

Authors:  Huw Smith; Mike Doenhoff; Cara Aitken; Wendi Bailey; Minjun Ji; Emily Dawson; Henk Gilis; Grant Spence; Claire Alexander; Tom van Gool
Journal:  PLoS Negl Trop Dis       Date:  2012-09-13

5.  Diagnostic accuracy of Kato-Katz and FLOTAC for assessing anthelmintic drug efficacy.

Authors:  Stefanie Knopp; Benjamin Speich; Jan Hattendorf; Laura Rinaldi; Khalfan A Mohammed; I Simba Khamis; Alisa S Mohammed; Marco Albonico; David Rollinson; Hanspeter Marti; Giuseppe Cringoli; Jürg Utzinger
Journal:  PLoS Negl Trop Dis       Date:  2011-04-12

6.  Application of DNA-based diagnostics in detection of schistosomal DNA in early infection and after drug treatment.

Authors:  Cen Wang; Lin Chen; Xuren Yin; Wanquan Hua; Min Hou; Minjun Ji; Chuanxin Yu; Guanling Wu
Journal:  Parasit Vectors       Date:  2011-08-24       Impact factor: 3.876

Review 7.  A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes.

Authors:  James S McCarthy; Sara Lustigman; Guo-Jing Yang; Rashida M Barakat; Héctor H García; Banchob Sripa; Arve Lee Willingham; Roger K Prichard; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

8.  Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.

Authors:  Sandra D Melman; Michelle L Steinauer; Charles Cunningham; Laura S Kubatko; Ibrahim N Mwangi; Nirvana Barker Wynn; Martin W Mutuku; Diana M S Karanja; Daniel G Colley; Carla L Black; William Evan Secor; Gerald M Mkoji; Eric S Loker
Journal:  PLoS Negl Trop Dis       Date:  2009-08-18

9.  Field testing of the WHO dose pole for administration of praziquantel in the treatment of opisthorchiasis in Lao PDR.

Authors:  H Strandgaard; M V Johansen; A Montresor; N Ørnbjerg
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-08-30       Impact factor: 2.184

10.  Longitudinal analysis of antigen specific response in individuals with Schistosoma mansoni infection in an endemic area of Minas Gerais, Brazil.

Authors:  Leonardo Ferreira Matoso; Roberta Oliveira-Prado; Mery Natali Silva Abreu; Ricardo Toshio Fujiwara; Philip T Loverde; Helmut Kloos; Andréa Gazzinelli; Rodrigo Correa-Oliveira
Journal:  Trans R Soc Trop Med Hyg       Date:  2013-11-04       Impact factor: 2.184
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.